🇺🇸 FDA
Patent

US 11612663

Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair

granted A61KA61K38/00A61K38/08

Quick answer

US patent 11612663 (Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair) held by The Regents of the University of California expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/39